You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 14 October 2025

Sec. Alloimmunity and Transplantation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1712602

Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

  • 1. Department of Medicine, University of British Columbia, Vancouver, BC, Canada

  • 2. Department of Medicine, Western University, London, ON, Canada

  • 3. Department of Medicine, McMaster University, Hamilton, ON, Canada

  • 4. Department of Surgery, McGill University, Montreal, QC, Canada

  • 5. Department of Medicine, University of Toronto, Toronto, ON, Canada

  • 6. Department of Medicine, Dalhousie University, Halifax, NS, Canada

  • 7. Department of Medicine, University of Alberta, Edmonton, AB, Canada

  • 8. Medical Affairs, Merck Canada Inc, Kirkland, QC, Canada

Article metrics

View details

978

Views

68

Downloads

There was a mistake in Figure 2 as published. The X axis legend was incorrect and should read: “Days from transplant to onset of the 1st episode of myelotoxicity”. The corrected Figure 2 appears below.

Figure 2

Line graph titled “Cumulative Incidence Function” depicting cumulative incidence over days from transplant to onset of the first episode of myelotoxicity. Three lines represent donor types: LD (red), DD (green), and Combined (black). All lines show similar upward trends, with a Gray's test p-value of 0.9992.

Cumulative incidence of myelotoxicity following transplantation.

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

cytomegalovirus, kidney transplantation, antiviral prophylaxis and treatment, immunosuppression, superinfection, leukopenia, hospitalization, graft failure

Citation

Gill J, House AA, Chagla Z, Tchervenkov J, Kim SJ, Vinson A, Cervera C, Keown PA, Sun SLW, Khoury C and Ghakis C (2025) Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada. Front. Immunol. 16:1712602. doi: 10.3389/fimmu.2025.1712602

Received

24 September 2025

Accepted

30 September 2025

Published

14 October 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Christiane Ghakis,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics